Publications by authors named "Eric Raefsky"

Claim this Profile
A
Amrubicin as second- or third-line treatment for women with metastatic HER2-negative breast cancer: a Sarah Cannon Research Institute phase 1/2 trial.
Denise A Yardley, Eric Raefsky, John D Hainsworth, Howard A Burris, Victor Priego

Breast Cancer Res Treat· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab with or without bevacizumab for the treatment of patients with relapsed follicular lymphoma.
John D Hainsworth, F Anthony Greco, Eric L Raefsky, Dana S Thompson, Scott Lunin

Clin Lymphoma Myeloma Leuk· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of neoadjuvant weekly nab-paclitaxel and carboplatin, with bevacizumab and trastuzumab, as treatment for women with locally advanced HER2+ breast cancer.
Denise A Yardley, Eric Raefsky, Raul Castillo, Anup Lahiry, Richard Locicero

Clin Breast Cancer· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pilot study of adjuvant nanoparticle albumin-bound (nab) paclitaxel and cyclophosphamide, with trastuzumab in HER2-positive patients, in the treatment of early-stage breast cancer.
Denise Yardley, Howard Burris, Nancy Peacock, Eric Raefsky, Marianne Melnik

Breast Cancer Res Treat· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tracheoesophageal fistula formation in patients with lung cancer treated with chemoradiation and bevacizumab.
David R Spigel, John D Hainsworth, Denise A Yardley, Eric Raefsky, Jeffrey Patton

J Clin Oncol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination therapy with fludarabine and rituximab followed by alemtuzumab in the first-line treatment of patients with chronic lymphocytic leukemia or small lymphocytic lymphoma: a phase 2 trial of the Minnie Pearl Cancer Research Network.
John D Hainsworth, Elizabeth R Vazquez, David R Spigel, Eric Raefsky, James D Bearden

Cancer· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination chemotherapy with gemcitabine and irinotecan in patients with previously treated carcinoma of an unknown primary site: a Minnie Pearl Cancer Research Network Phase II trial.
John D Hainsworth, David R Spigel, Eric L Raefsky, Michel E Kuzur, Kathleen Yost

Cancer· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I trial of protracted oral fixed-dose temozolomide.
Suzanne F Jones, F Anthony Greco, Victor G Gian, Fernando T Miranda, Eric L Raefsky

Cancer· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I/II study of exisulind in combination with docetaxel/carboplatin in patients with metastatic non-small-cell lung cancer.
Suzanne F Jones, John G Kuhn, F Anthony Greco, Eric L Raefsky, John D Hainsworth

Clin Lung Cancer· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weekly paclitaxel, estramustine phosphate, and oral etoposide in the treatment of hormone-refractory prostate carcinoma: results of a Minnie Pearl Cancer Research Network phase II trial.
Anthony A Meluch, F Anthony Greco, Lisa H Morrissey, Eric L Raefsky, Ronald G Steis

Cancer· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I. Trial of irinotecan plus carboplatin in two dose schedules.
Suzanne F Jones, Howard A Burris, John D Hainsworth, Denise A Yardley, Eric A Raefsky

Oncology (Williston Park)· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of JM-216 (an oral platinum analogue) in combination with paclitaxel in patients with advanced malignancies.
Suzanne Jones, John Hainsworth, Howard A Burris, Dana Thompson, Eric Raefsky

Invest New Drugs· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis